As of January 22, 2025, Puma Biotechnology (PBYI) has a market cap of $0.14 billion USD. According to our data, Puma Biotechnology is ranked No.7402 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.14 B |
-3.28%
|
Dec 31, 2024 | $0.15 B |
-29.56%
|
Dec 29, 2023 | $0.21 B |
2.36%
|
Dec 30, 2022 | $0.21 B |
39.14%
|
Dec 31, 2021 | $0.15 B |
-70.37%
|
Dec 31, 2020 | $0.50 B |
17.26%
|
Dec 31, 2019 | $0.43 B |
-57.00%
|
Dec 31, 2018 | $1.00 B |
-79.41%
|
Dec 29, 2017 | $4.85 B |
221.99%
|
Dec 30, 2016 | $1.51 B |
-60.84%
|
Dec 31, 2015 | $3.85 B |
-58.58%
|
Dec 31, 2014 | $9.29 B |
82.82%
|
Dec 31, 2013 | $5.08 B |
452.16%
|
Dec 31, 2012 | $0.92 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Genmab
GMAB
|
$13.32 B |
0.000 M
|
Denmark
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Array Technologies
ARRY
|
$0.97 B |
0.000 M
|
USA
|
Agios Pharmaceuticals
AGIO
|
$1.94 B |
-0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
Syndax Pharmaceuticals
SNDX
|
$1.20 B |
0.000 M
|
USA
|
Karyopharm Therapeutics
KPTI
|
$84.09 M |
0.000 M
|
USA
|
Market Cap | = | PBYI Stock Price | * | PBYI Shares Outstanding |
= | $2.95 | * | 49.09 M | |
= | $0.14 B |